News Search Results
Jan 09, 2026, 15:49 ET Piramal Pharma Achieves Notable Score Increase on 2025 S&P Global Corporate Sustainability Assessment (CSA)
associate companies, Abbvie Therapeutics India Private Limited, a joint venture between Abbvie and PPL, has emerged as one of the market leaders in the ophthalmology therapy area in the Indian pharma market. Further, PPL has a strategic minority investment in Yapan Bio Private Limited, that operates in the biologics
More news about: Piramal Pharma Limited
Jan 09, 2026, 15:43 ET Piramal Pharma Achieves Notable Score Increase on 2025 S&P Global Corporate Sustainability Assessment (CSA)
associate companies, Abbvie Therapeutics India Private Limited, a joint venture between Abbvie and PPL, has emerged as one of the market leaders in the ophthalmology therapy area in the Indian pharma market. Further, PPL has a strategic minority investment in Yapan Bio Private Limited, that operates in the biologics
More news about: Piramal Pharma Limited
Jan 09, 2026, 14:33 ET Nanodropper® Now Operating as Mu Medical™, Planned Expansion of Precision Eyecare Platform with Bedo Solutions and Viseon Labs
https://www.mitcnc.org/events/150561About Mu MedicalMu Medical is a physician-founded, commercial-stage medtech company advancing precision and personalized care in ophthalmology. Upon closing of the proposed transactions, Mu Medical will bring together Nanodropper, Bedo Solutions, and Viseon Labs to develop solutions spanning
More news about: Mu Medical
Jan 09, 2026, 13:23 ET Bill Hutchinson, CEO of Dunhill Partners, Champions Community-Centric Retail with Acquisition of Northpark Village in Lubbock
United Supermarkets (Albertsons family), providing deep-rooted brand loyalty.Healthcare & Wellness: Lubbock Ophthalmology and Abbeville Dentistry.Daily Services: Officialz Barbershop, Palm Beach Tan, and Relaxing House Spa.Dining
More news about: Dunhill Partners
Jan 09, 2026, 08:00 ET Press Registration Is Now Open for the 2026 ACMG Annual Clinical Genetics Meeting
Clinical GeneticsHot Topics in Washington, DC: Impacts to Medical GeneticsPre-Conference Sessions — Genetic Therapies Bootcamp; Ophthalmology & Genetics Symposium; and moreAfternoon and Evening Corporate Educational Satellite SymposiaIn addition to the
More news about: American College of Medical Genetics and Genomics
Jan 08, 2026, 19:00 ET Innovent's Partner Ollin Biosciences Announces Positive Topline Data with Superior Outcomes from a Randomized Head-to-Head Study of IBI324 Compared to Faricimab (Vabysmo®) in Diabetic Macular Edema and Wet Age-Related Macular Degeneration
that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology and other major disease areas, today announced that the company's partner Ollin reported positive topline results from its randomized, head-to-head
More news about: Innovent Biologics
Jan 08, 2026, 10:30 ET VYLOY™ (zolbetuximab) Plus Chemotherapy Associated with Enhanced Survival Outcomes when Common Adverse Events are Effectively Managed, According to New Ad Hoc Analyses
company committed to turning innovative science into value for patients. We provide transformative therapies in disease areas that include oncology, ophthalmology, urology, immunology and women's health. Through our research and development programs, we are pioneering new healthcare solutions for diseases
More news about: Astellas Pharma Inc.
Jan 08, 2026, 09:00 ET CBCC Global Research Rebrands to REV Clinical to Reflect Next Stages of Growth
organization ("CRO") with deep experience in designing and managing clinical trials across its core therapeutic areas, including oncology, neurology, ophthalmology, and rare diseases, today announced the launch of its comprehensive rebrand and name change to REV Clinical, reflecting the organization's focus
More news about: REV Clinical
Jan 08, 2026, 09:00 ET Verana Health Merges with COTA to Dramatically Expand Scale, Velocity, and Depth of Real-World Data Offerings Across Oncology and Other Specialties
delivered on.With its focus on real-world patient data in oncology, COTA complements Verana Health data and technology offerings across ophthalmology, urology, and neurology. The combined portfolio supports life sciences companies with clinical trials, drug submissions, health economics research,
More news about: Verana Health
Jan 08, 2026, 07:00 ET InMode to Report Fourth Quarter & Full Year 2025 Financial Results and Hold Conference Call on February 10, 2026, Expects Q4 Revenue Between $103.6M-$103.8M
technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode, please visit www.inmodemd.com.Forward-Looking
More news about: InMode Ltd.
Jan 08, 2026, 07:00 ET RVL Pharmaceuticals Announces Santen Obtains Manufacturing and Marketing Approval in Japan for UPNEEQ® Mini Ophthalmic Solution 0.1%
/PRNewswire/ -- RVL Pharmaceuticals, Inc. and its affiliates (together, "RVL") announces Santen Pharmaceutical Co., Ltd. ("Santen"), a leading ophthalmology company has obtained the manufacturing and marketing approval in Japan for UPNEEQ® Mini Ophthalmic Solution 0.1% (generic name:
More news about: RVL Pharmaceuticals, Inc
Jan 08, 2026, 03:00 ET Nearly 90 Physicians from MemorialCare's Long Beach Medical Center, Miller Children's & Women's Hospital Recognized by Leading Doctor's Report
Oncology, Infectious Disease, Maternal/Fetal Medicine, Neonatal/Perinatal Medicine, Neurology, Neurological Surgery, Obstetrics/Gynecology, Oncology, Ophthalmology, Orthopaedic Surgery, Pediatric Surgery, Pediatrics, Plastic Surgery, Pulmonary Medicine, Radiology, Rheumatology, Sleep Medicine, Surgery, General,
More news about: MemorialCare Long Beach Medical Center and Miller Children's & Women's Hospital
Jan 07, 2026, 11:56 ET CooperVision wprowadza na rynek jednodniowe miękkie soczewki kontaktowe MyDay® MiSight® 1 day do kontroli krótkowzroczności
temporal trends from 2000 through 2050 (Występowanie krótkowzroczności i wysokiej krótkowzroczności na świecie, tendencje czasowe w latach 2000-2050). Ophthalmology. 2016;123(5):1036-1042E. L. Lamoureux i in. Myopia and Quality of Life: The Singapore Malay Eye Study (SiMES) (Krótkowzroczność a jakość
More news about: CooperVision, Inc.
Jan 07, 2026, 10:03 ET AMSURG Centers Earn National Recognition in 2025 Press Ganey Human Experience Awards
health systems, the organization delivers high-quality patient care across a diverse spectrum of medical specialties, including gastroenterology, ophthalmology and orthopedics. Guided by its core values — Care Deeply, Champion Excellence, Cultivate Integrity and Celebrate Teamwork — AMSURG is committed
More news about: AMSURG Corporation
Jan 07, 2026, 08:08 ET Ascend Vision Partners Enters Oklahoma Market with the Acquisition of 3 Leading Ophthalmology Practices
premier retinal specialty practice providing advanced medical and surgical retina careWise Eye Associates, offering comprehensive ophthalmology services with a long-standing reputation for clinical excellenceSylvester Eye Care & Aesthetics, delivering integrated eye care
More news about: Ascend Vision Partners
Jan 06, 2026, 18:42 ET Celltrion to present at the 44th Annual J.P. Morgan Healthcare Conference
monoclonal antibody biosimilar. Our global pharmaceutical portfolio addresses a range of therapeutic areas including immunology, oncology, hematology, ophthalmology and endocrinology. Built on trust through our fully integrated capabilities – from advanced R&D and in-house manufacturing to a reliable global
More news about: Celltrion
Jan 06, 2026, 18:30 ET Astellas to Present at 44th Annual J.P. Morgan Healthcare Conference
company committed to turning innovative science into VALUE for patients. We provide transformative therapies in disease areas that include oncology, ophthalmology, urology, immunology and women's health. Through our research and development programs, we are pioneering new healthcare solutions for diseases
More news about: Astellas Pharma Inc.
Jan 06, 2026, 12:15 ET CooperVision bringt weiche MyDay® MiSight® 1 day Kontaktlinsen zur Myopie-Kontrolle auf den Markt
Datei, 2025.Holden BA, Fricke TR, Wilson DA, et al. Globale Prävalenz von Myopie und hoher Myopie und zeitliche Trends von 2000 bis 2050. Ophthalmology. 2016;123(5):1036-1042E. L. Lamoureux et al. Myopia and Quality of Life: Die Singapore Malay Eye Study (SiMES). IOVS 2008;49(13):4469.Chua
More news about: CooperVision, Inc.
Jan 06, 2026, 11:00 ET VivaVision Biotech Receives Positive Written Feedback from FDA - VVN461HD New Drug Application (NDA) Requires Only a "Single Phase III" Pivotal Clinical Study in the U.S. for Non-Infectious Anterior Uveitis Treatment
efficacy, reflecting the clinical development and execution capabilities of the VivaVision team. We look forward to achieving more breakthroughs with ophthalmology drugs represented by VVN461HD in the future. At the same time, we are very grateful for the FDA's recognition of the Phase II clinical trial of
More news about: VivaVision Biotech
Jan 06, 2026, 10:56 ET Společnost CooperVision uvede na trh měkké kontaktní čočky MyDay® MiSight® 1 day pro kontrolu krátkozrakosti
archivu, 2025Holden BA, Fricke TR, Wilson DA, et al. Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology. 2016;123(5):1036-1042E. L. Lamoureux et al. Myopia and Quality of Life: The Singapore Malay Eye Study (SiMES). IOVS 2008;49(13):4469.Chua
More news about: CooperVision, Inc.
Jan 06, 2026, 08:28 ET CooperVision lanzará las lentes de contacto blandas MyDay® MiSight® de 1 día para el control de la miopía
file, 2025Holden BA, Fricke TR, Wilson DA, et al. Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology. 2016;123(5):1036-1042E. L. Lamoureux et al. Myopia and Quality of Life: The Singapore Malay Eye Study (SiMES). IOVS 2008;49(13):4469.Chua
More news about: CooperVision, Inc.
Jan 06, 2026, 08:00 ET CooperVision to Launch MyDay® MiSight® 1 day Myopia Control Soft Contact Lenses
file, 2025Holden BA, Fricke TR, Wilson DA, et al. Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology. 2016;123(5):1036-1042E. L. Lamoureux et al. Myopia and Quality of Life: The Singapore Malay Eye Study (SiMES). IOVS 2008;49(13):4469.Chua
More news about: CooperVision, Inc.
Jan 05, 2026, 18:55 ET Everest Medicines to Present at the 44th Annual J.P. Morgan Healthcare Conference
Medicines has built a portfolio of potentially global first-in-class or best-in-class molecules in the company's core therapeutic areas of autoimmune, ophthalmology, critical care, and CKM (cardiovascular, kidney, and metabolic). For more information, please visit its website at
More news about: Everest Medicines
Dec 30, 2025, 13:54 ET Parker Waichman LLP Files Lawsuit on behalf of Philadelphia Resident Alleging Development of Irreversible Eye Condition, NAION, after taking Ozempic
concerns about the failure of drug manufacturers to warn consumers and medical professionals about these risks.A 2025 study published in JAMA Ophthalmology examined nine patients who developed optic nerve disorders after using GLP-1 medications, with the majority suffering from
More news about: Parker Waichman LLP
Dec 29, 2025, 09:00 ET Costa Rica Strengthens Its Global Leadership in Medical Devices, Exporting Innovation to the World
Ireland, Sweden, Japan, Spain and other markets operate in the country, covering specialized areas such as endoscopy, cardiology, orthopedics, ophthalmology, diagnostics and advanced surgical solutions.This performance reflects Costa Rica's transition toward an economy driven by innovation, advanced
More news about: PROCOMER